Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀڱðæºÎ¾Ï ȯÀÚ ºÎºÎ¿¡¼­ ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º °¨¿°·Â °áÁ¤À» À§ÇÑ ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º 16Çü »ó·ùÀü»ç Á¶Àý ºÎÀ§ ¿°±â¼­¿­ º¯Ã¼ ºñ±³ Comparison of HPV 16 Sequence Variations at Upstream Regulatory Region in the Couples of Patients with Cervical Cancer for Determination of HPV Infectivity

´ëÇѾÏÇÐȸÁö 1999³â 31±Ç 2È£ p.403 ~ 410
¼Ò¼Ó »ó¼¼Á¤º¸
±èÀç¿ø/Jae Weon Kim ¼Û¿ë»ó/ÀüÇý¿ø/¹Ú³ëÇö/°­¼ø¹ü/ÀÌÈ¿Ç¥/Yong Sang Song/Hye Won Jeon/Noh Hyun Park/Soon Beom Kang/Hyo Pyo Lee

Abstract

¼­·Ð
ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º(Human papillomavirus, HPV) °¨¿°¿¡ ÀÇÇÑ ¾Ç¼ºÁúȯ Áß ´ëÇ¥ÀûÀÎ ÀÚ
±Ã°æºÎ¾ÏÀº Àü¼¼°èÀûÀ¸·Î ¸Å³â ¾à 46¸¸¸íÀÇ ½ÅȯÀÌ ¹ß»ýÇϸç Çѱ¹¿¡¼­´Â ¿©¼º¾Ï Áß ¹ß»ýºó
µµ 1À§¸¦ Â÷ÁöÇÏ°í ÀÖ´Ù. HPV °¨¿°°ú ÀڱðæºÎ¾ÏÀÇ °ü°è¿¡ ´ëÇؼ­´Â 1990³â´ë ÃʱîÁö¸¸ ÇØ
µµ Àΰú°ü°è°¡ °­·ÂÈ÷ Àǽɵdzª °áÁ¤ÀûÀÎ °ÍÀº ¾Æ´Ï¶ó´Â °ßÇØ°¡ ÀÖ¾úÀ¸³ª ÃÖ±ÙÀÇ ¿©·¯ ¿ªÇÐ
Àû, ½ÇÇèÀû ¿¬±¸ °á°ú¿¡ µû¸£¸é HPV °¨¿°ÀÌ ÀڱðæºÎ¾Ï ¹ß»ýÀÇ Áß¿äÇÑ ¿øÀÎÀÎÀÚ¶ó´Â ÁÖÀå
¿¡´Â ÀÌ·ÐÀÌ ¾ø´Â »óȲÀÌ´Ù.
HPV °¨¿°ÀÇ ÀüÆÄ °æ·Î¿¡ °üÇؼ­´Â 19¼¼±â¿¡ Rigoni-Stern¿¡ ÀÇÇØ ÀڱðæºÎ¾Ï ¹ß»ý°ú ¼º
»ýÈ°°úÀÇ ¿¬°ü¼ºÀÌ º¸°íµÈ ÀÌ·¡ ¿©·¯ ¿ªÇÐÀû »ç½ÇÀÌ ¹àÇôÁ® ¿Ô´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ¿ªÇÐÀû ±Ù
°Å¸¦ Á¦¿ÜÇÏ°í´Â »ý½Ä±â °¨¿° HPV°¡ ¼ºÀû Á¢ÃËÀ» ÅëÇÏ¿© ÀüÆĵȴٰųª »ý½Ä±â Á¾¾çÀ» ¼º
º´À¸·Î °£ÁÖÇÒ ¸¸ÇÑ °úÇÐÀû, ½ÇÇèÀû ±Ù°Å¸¦ Á¦½ÃÇÑ ¿¬±¸´Â µå¹°´Ù. Áö±Ý±îÁö ¾Ë·ÁÁø ¹Ù·Î´Â
¾ç¼º »ý½Ä±â À¯µÎÁ¾À» À¯¹ßÇÏ´Â HPV¿¡ ÇǺλóÇÇ°¡ ³ëÃâµÇ´õ¶óµµ ¹Ù·Î Áúº´À» À¯¹ßÇÏÁö´Â
¾Ê´Â´Ù. µû¶ó¼­ ¼º±³½ÃÀÇ »ý½Ä±â »óÇÇ Á¢Ã˵µ ÀÌ¿Í Å©°Ô ´Ù¸£Áö´Â ¾ÊÀ» °ÍÀÌ°í ¼ºÀû ÀüÆÄ
°æ·Î ÀÌ¿Ü¿¡ ´Ù¸¥ ÀüÆÄ °æ·ÎÀÇ °¡´É¼º, ¿¹¸¦ µé¸é Àڱó», ½Å»ý¾Æ±â, ¼Ò¾Æ±âÀÇ ºñ¼ºÀû ÀüÆÄ
ÀÇ °¡´É¼ºµµ °í·ÁµÇ¾î¾ß ÇÑ´Ù. ¼º¹è¿ìÀÚ¿¡¼­ ¼Òº¯, Á¤¾× ȤÀº ¿ä·Î ÀÔ±¸¿¡¼­ ¸éºÀÀ¸·Î ¼¼Æ÷
¸¦ äÃëÇÏ¿© HPVÀÇ °¨¿°¿©ºÎ¸¦ È®ÀÎÇÔÀ¸·Î¼­ ¼ºÀûÀüÆÄ °¡´É¼ºÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ´Â ¿©·¯ ½Ã
µµ°¡ ÀÖ¾úÀ¸³ª ´ë»óȯÀÚ¼ö°¡ Àû°í, ¼¼Æ÷¸¦ äÃëÇÏ´Â À§Ä¡, ¹æ¹ý, HPV¸¦ °Ë»öÇÏ´Â ¹æ¹ý¿¡ Â÷
ÀÌ°¡ ÀÖ¾î ´Ù¾çÇÑ °á°ú¸¦ º¸ÀÌ°í ÀÖ´Ù.
ÃÖ±Ù HPV ¿°±â¼­¿­ º¯ÀÌ¿¡ °üÇÑ ¿¬±¸¿¡ µû¸£¸é ƯÁ¤ ºÎÀ§ÀÇ º¯ÀÌ´Â ¹«ÀÛÀ§ÀûÀ¸·Î ÇÑ °³
ü ³»¿¡¼­ ´Ü±â°£¿¡ ÃâÇöÇÏ´Â °ÍÀÌ ¾Æ´Ï°í Àå±â°£¿¡ °ÉÃÄ ´À¸° ¼Óµµ·Î ÀηùÀÇ ÁøÈ­¿Í ÇÔ²²
³ªÅ¸³ª´Â °ÍÀ¸·Î ¹àÇôÁ³´Ù. Ongµî¿¡ ÀÇÇϸé ÇÑ ºÎÀ§¿¡ Á¡º¯ÀÌ°¡ ¹ß»ýÇϴµ¥ °É¸®´Â ±â°£Àº
ÃÖ¼Ò 12,000³â·Î ÃßÁ¤ÇÏ°í ÀÖ´Ù. µû¶ó¼­ ¼º¹è¿ìÀÚ°£¿¡ HPV ¿°±â¼­¿­ ºÐ¼®»ó ÀÏÄ¡µÈ °á°ú¸¦
º¸ÀÎ´Ù¸é ¿ªÇÐÀû Áõ°Å¿Í´Â ´Ù¸¥ ½ÇÇèÀû Ãø¸é¿¡¼­ ¼ºÀû ÀüÆÄ °æ·Î¸¦ Áõ¸íÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÌ
´Ù.
º» ¿¬±¸¿¡¼­´Â »õ·Ó°Ô ÀڱðæºÎ¾ÏÀ¸·Î Áø´ÜµÈ ȯÀÚ¿Í ±× ¼ºÀû »ó´ëÀÚÀÎ ¹è¿ìÀÚ¿¡¼­ HPV
16Çü »ó·ùÀü»ç Á¶ÀýºÎÀ§(upstream regulatory region; URR)ÀÇ ¿°±â¼­¿­À» ºñ±³ÇÔÀ¸·Î½á °í
µµÀÇ Á¤È®¼ºÀ» °¡Áö°í ÀüÆÄ°æ·Î¸¦ ¹àÈ÷°í µ¿½Ã¿¡ HPVÀÇ °¨¿°·Â¿¡ ´ëÇÑ Á¤º¸¸¦ ¾ò°íÀÚ ÇÏ
¿´´Ù.

Purpose : Although it is now generally accepted that human papillomaviruses (HPVs)
are causally related to cervical neoplasia by plentiful epidemiologic and experimental
works, little is known about the direct evidence of sexual transmission of HPV. This
study was undertaken to confirm the transmission route and determine the infectivity of
HPV by comparison of HPV 16 sequence variations at upstream regulatory region
(URR) in the couples of patient with cervical cancer.
Materials and Methods : HPV DNAs obtained from genital lesions of forty married
couples of patients with cervical cancer were evaluated by polymerase chain reaction
(PCR) and PCR-directed sequencing.
Results : HPV 16 was detected in fourteen (63.6%) of twenty-two male consorts
whose wives were positive for HPV 16. Of these, six (42.9%) couples demonstrated
identical HPV 16 URR variants between patients and male consorts, and eight had
mismatching HPV 16 URR sequences. Among six couples showed matching HPV 16
variants, three couples married for 10, 19, 25 years respectively carried variant
7728/7779, two couples married for 15 years each carried variant 7728/7762, and one
couple married for 18 years carried variant 7728/7797.
Conclusion : These data suggest that sexual transmission of HPV 16 does occur.4
search for more HPV variants in a large cohort is needed to secure high level of
precision in molecular epidemiologic study using HPV variant.

Å°¿öµå

HPV 16; Variants; Molecular epidemiology;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS